News Conference News TCT 2025 Trials Bolster Alternatives to Intravascular Lithotripsy for Calcified Lesions Todd Neale October 26, 2025
News Conference News EuroPCR 2025 IVL Effective in Severely Calcified Lesions, Especially in Women Yael L. Maxwell May 22, 2025
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Conference News TCT 2021 Disrupt CAD III Shows Sustained Benefit for Lithotripsy at 1 Year L.A. McKeown November 05, 2021
News Conference News VIVA 2020 DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD L.A. McKeown November 09, 2020
News Conference News TCT 2020 DISRUPT CAD III: Lithotripsy Boosts Stent Expansion in Highly Calcified Lesions L.A. McKeown October 15, 2020
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
News Conference News AHA 2017 Circling Back on ORBITA: Sham-Controlled PCI Trial Makes Best of 2017 List Michael O'Riordan November 12, 2017
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016